Gencurix Inc Total Liabilities

Latest as of June 2026: ₩18.57 Billion KRW ≈ $12.58 Million USD

Gencurix Inc total liabilities. Based on the latest financial reports, Gencurix Inc (229000) has total liabilities worth ₩18.57 Billion KRW (≈ $12.58 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 229000 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Gencurix Inc (2016–2025)

Total liabilities of Gencurix Inc from 2016 to 2025. This chart illustrates how Gencurix Inc's total liabilities have evolved over time, based on quarterly financial data.

Gencurix Inc Competitors by Total Liabilities

The table below lists competitors of Gencurix Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Unifin Financiera S. A. B. de C. V MX:UNIFINA	Mexico	MX$83.80 Billion
Mega Perintis Tbk PT JK:ZONE	Indonesia	Rp322.51 Billion
Battalion Oil Corp NYSE MKT:BATL	USA	$511.94 Million
Auric Mining Ltd AU:AWJ	Australia	AU$2.05 Million
K Way Information TWO:5201	Taiwan	NT$264.47 Million
TINYBUILD REGSCAT3 DL-001 F:8Z3	Germany	€11.50 Million
Fridenson TA:FRDN	Israel	ILA185.56 Million
Rekah Pharmaceutical Industry Ltd TA:REKA	Israel	ILA281.29 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Gencurix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Gencurix Inc.

Liquidity & Leverage Metrics

Gencurix Inc Total Liabilities Ratios Explained

Gencurix Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.47	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gencurix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gencurix Inc (2016–2025)

The table below shows the annual total liabilities of Gencurix Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩15.74 Billion ≈ $10.67 Million	+3.90%
2024-12-31	₩15.15 Billion ≈ $10.27 Million	-29.54%
2023-12-31	₩21.50 Billion ≈ $14.57 Million	-30.12%
2022-12-31	₩30.76 Billion ≈ $20.85 Million	+26.62%
2021-12-31	₩24.30 Billion ≈ $16.47 Million	+129.19%
2020-12-31	₩10.60 Billion ≈ $7.18 Million	+374.88%
2019-12-31	₩2.23 Billion ≈ $1.51 Million	+136.53%
2018-12-31	₩943.77 Million ≈ $639.58K	-1.26%
2017-12-31	₩955.78 Million ≈ $647.72K	-7.10%
2016-12-31	₩1.03 Billion ≈ $697.21K	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$31.07 Million

₩45.85 Billion KRW

Market Cap Rank

#23395 Global

#1605 in Korea

Share Price

₩1957.00

Change (1 day)

+0.88%

52-Week Range

₩1400.00 - ₩5870.00

All Time High

₩23845.65